BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2024 8:28:54 AM | Browse: 219 | Download: 1268
Publication Name World Journal of Clinical Oncology
Manuscript ID 97733
Country China
Received
2024-06-06 11:00
Peer-Review Started
2024-06-06 11:00
First Decision by Editorial Office Director
2024-07-24 11:11
Return for Revision
2024-07-24 11:11
Revised
2024-08-05 11:43
Publication Fee Transferred
2024-08-09 09:54
Second Decision by Editor
2024-08-07 02:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2024-08-07 06:13
Articles in Press
2024-08-07 06:13
Edit the Manuscript by Language Editor
2024-08-16 23:43
Typeset the Manuscript
2024-08-22 00:27
Publish the Manuscript Online
2024-08-29 08:28
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Respiratory System
Manuscript Type Basic Study
Article Title Anti-inflammatory effects of Tao Hong Si Wu Tang in mice with lung cancer and chronic obstructive pulmonary disease
Manuscript Source Unsolicited Manuscript
All Author List Guo-Li Wang, Yan-Ling Xu, Ke-Ming Zhao, Ai-Feng Sui, Li-Na Wang, Hu Deng and Ge Wang
ORCID
Author(s) ORCID Number
Ge Wang http://orcid.org/0009-0009-3310-6497
Funding Agency and Grant Number
Funding Agency Grant Number
Liaoning Province “Xingliao Talent Program” Project XLYC2007019
Corresponding Author Ge Wang, MSc, Associate Chief Physician, Department of Spleen and Stomach Oncology, The Fourth Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, No. 9 Xuesong Road, Sujiatun District, Shenyang 110101, Liaoning Province, China. 895125868@qq.com
Key Words Tao Hong Si Wu Tang; Anti-inflammatory; Chronic obstructive pulmonary disease; Lung cancer; Traditional Chinese medicine
Core Tip The present study aimed to analyze the anti-inflammatory effects of Tao Hong Si Wu Tang (THSW) in a chronic obstructive pulmonary disease-lung cancer mouse model and elucidate its anti-inflammatory principle in inhibiting the pathogenesis of positive-feedback inflammatory response through detecting the signaling pathway that may be induced by the inflammatory factors. Moreover, the findings are intended to lay the theoretical foundation and provide a guide for the clinical application of THSW.
Publish Date 2024-08-29 08:28
Citation

Wang GL, Xu YL, Zhao KM, Sui AF, Wang LN, Deng H, Wang G. Anti-inflammatory effects of Tao Hong Si Wu Tang in mice with lung cancer and chronic obstructive pulmonary disease. World J Clin Oncol 2024; 15(9): 1198-1206

URL https://www.wjgnet.com/2218-4333/full/v15/i9/1198.htm
DOI https://dx.doi.org/10.5306/wjco.v15.i9.1198
Full Article (PDF) WJCO-15-1198-with-cover.pdf